Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AMRX - FDA OKs Amneal Pharmaceuticals' Acyclovir cream


AMRX - FDA OKs Amneal Pharmaceuticals' Acyclovir cream

The FDA has approved Amneal Pharmaceuticals' ([[AMRX]]) Abbreviated New Drug Application ((ANDAs)) for Acyclovir Cream, 5% a generic version of Zovirax for treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years and older.The product is available by prescription only and is associated with mild side effects such as nausea.Per IQVIA, the U.S. market annual sales for Acyclovir Cream, 5% is ~$67M.Shares are up 4.8% PM.

For further details see:

FDA OKs Amneal Pharmaceuticals' Acyclovir cream
Stock Information

Company Name: Amneal Pharmaceuticals Inc. Class A
Stock Symbol: AMRX
Market: NASDAQ
Website: amneal.com

Menu

AMRX AMRX Quote AMRX Short AMRX News AMRX Articles AMRX Message Board
Get AMRX Alerts

News, Short Squeeze, Breakout and More Instantly...